Loretta Johnson

Loretta Johnson Email and Phone Number

Senior Clinical Research Associate @ ICON Strategic Solutions
Loretta Johnson's Location
Tampa, Florida, United States, United States
Loretta Johnson's Contact Details

Loretta Johnson work email

Loretta Johnson personal email

n/a
About Loretta Johnson

Clinical monitoring - Phase II, III, and IV Clinical trials.Specialties: Cardiovascular (coronary artery by-pass graft surgery, ST-elevation myocardial infarction, Stress myocardial perfusion imaging and Coumadin)Cardiovascular by-pass Stent (device study)Breast Agumentation (device study)Diabetes Mellitus (hypercholesterolemia)Pain (gout)Pain (adult migraines) Rheumatology (rheumatoid arthritis)Gynecology (post-menopausal) Hot flash Infectious Disease (Adult flu vaccine)Rare Disease

Loretta Johnson's Current Company Details
ICON Strategic Solutions

Icon Strategic Solutions

View
Senior Clinical Research Associate
Loretta Johnson Work Experience Details
  • Icon Strategic Solutions
    Senior Cra /Functional Service Provider
    Icon Strategic Solutions Mar 2024 - Present
    United States
    Vaccine Trial: A Phase III randomized double-blind controlled study to evaluate the immunogenicity, safety and reactogenicity of ExPEC9V and High-dose Quadrivalent Influenza Vaccine with and without Co-administration, in adults aged 65 years and Older.6 assign sites - Pre-study, SIV, MV, COV
  • Icon Strategic Solutions
    Senior Cra /Functional Service Provider
    Icon Strategic Solutions Apr 2022 - Mar 2024
    United States
    Depression Treatment Resistant Trial: A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy, safety, and tolerability of Esketamine nasal spray, administered as monotherapy for treatment-resistant depression6 assigned sites - MV and COV
  • Icon Strategic Solutions
    Senior Cra / Functional Service Provider
    Icon Strategic Solutions Mar 2020 - Mar 2022
    United States
    Multiple Sclerosis Trial: A phase III, double-blind efficacy and safety study comparing SAR442168 to participants with non-relapsing secondary progressive multiple sclerosis – Four sister protocols8 assigned sites - MV, COV
  • Icon Strategic Solutions
    Senior Cra
    Icon Strategic Solutions Jul 2018 - Jul 2020
    United States
    IBS with Constipation Trial: Second phase III Randomized, 12-week, double-blind Placebo-Controlled Study of the Safety and Efficacy of XXX in patients with irritable bowel syndrome and Constipation (IBS-C)12 sites - Pre-study, SIV, IMV, COV
  • Icon Strategic Solutions
    Senior Cra
    Icon Strategic Solutions Aug 2019 - Feb 2020
    Infectious Disease Trial: A Phase II Randomized and Controlled Investigation of Six Weeks of Oral XXX Therapy in Infants and Children with Congenital Cytomegalovirus Infection and Hearing Loss8 assigned sites - COV’s only
  • Icon Strategic Solutions
    Senior Cra
    Icon Strategic Solutions May 2015 - Jun 2018
    United States
    Cardiovascular Disease and Glucose Abnormalities Trial: A phase III trial to confirm the anti-anginal Effect of XXX in patients with stable angina.10 assigned sites - IMV, COV
  • Icon Strategic Solutions
    Senior Cra
    Icon Strategic Solutions Dec 2013 - Apr 2015
    United States
    Post Menopausal Women with Vasomotor Symptoms Trial: A Phase II interventional trial, multi-center, double-blind, randomized, placeo-controlled multiple ascending dose study in post-menopausal women with vasomotor symptoms.5 assigned sites - Pre-study, SIV, IMV, COV
  • Icon Strategic Solutions
    Senior Cra
    Icon Strategic Solutions Nov 2010 - Dec 2013
    United States
    Type II Diabetes Trial: A Phased III multicenter, randomized, double-blind, Placebo-Controlled trial evaluating the safety and Efficacy XXX in subjects with Type 2 Diabetes with inadequately controlled hypertension.8 assigned sites - Pre-study, SIV, IMV, COV
  • Aerotek
    Clinical Research Associate Ii
    Aerotek Feb 2008 - Oct 2010
    United States
    Cardiovascular Trial: Contract CRA II for IQVIA (formerly Quintiles), A Phase III, Randomized trial for treatment with a novel thienopyridine, prasugrel, compared with clopidogrel among patients undergoing planned percutaneous coronary intervention (PCI) for an acute coronary syndrome (ACS)Assisted with data cleaning (queries, site contact and follow-up) in preparation for database lock.2 assigned sites - IMV, COV
  • Aerotek
    Clinical Research Associate Ii
    Aerotek Jul 2007 - Jan 2008
    United States
    Breast Argumentation Device Trial: Contract CRA II for IQUIVA (formerly Quintiles), A Phase III trial, to assess outcomes, satisfaction and aesthetics of two different breast reconstruction techniques and compare its safety, patient satisfaction, aesthetic evaluation and complications1 site - pre-study, SIV, IMV, COV
  • Icon Strategic Solutions
    Clinical Research Associate Ii
    Icon Strategic Solutions Jul 2004 - Jun 2007
    United States
    General Gastrointestinal Trial: A Phase III study (General Gastrointestinal- IBS with constipation8 assigned sites – IMV, COV
  • Icon Strategic Solutions
    Cra I
    Icon Strategic Solutions Feb 2002 - Jul 2004
    United States
    Hypertension with Type II Diabetes Trial: A Multicenter, randomized, double-blind, Placebo-Controlled, Phase III Trial evaluating the Safety and Efficacy XXX in subjects with Type 2 Diabetes with inadequately Controlled hypertension6 assigned sites - Pre-study, SIV, IMV, COV
  • Icon Strategic Solutions
    Clinical Trials Assistant (Cta)
    Icon Strategic Solutions Aug 2001 - Feb 2002
    Hypercholesterolemia Trial: An open label, randomized, Phase IIIb, study comparing the efficacy and safety of XXX in high-risk subjects with Type IIa and IIb Hypercholesterolemia Supported the administrative and logistical aspects of clinical trials for multiple studies ensuring the smooth operation and management of clinical studies

Loretta Johnson Skills

Gcp Clinical Trials Clinical Monitoring Clinical Research Ctms Edc Cro Ich Gcp Clinical Development Oncology Regulatory Submissions Clinical Data Management Pharmaceutical Industry Regulatory Affairs Infectious Diseases Irb Cardiology Medical Writing Medicine Rheumatology Inform Endocrinology Lifesciences Neurology Therapeutic Areas Biotechnology Ind Diabetes Oracle Clinical Crf Design Pain Management Pharmacology Sop Drug Development Fda Clinical Study Design Immunology Pharmacovigilance Central Nervous System Data Management Medical Devices Trial Management Medidata Rheumatoid Arthritis Vaccines Hematology Clinical Operations Life Sciences

Loretta Johnson Education Details

Frequently Asked Questions about Loretta Johnson

What company does Loretta Johnson work for?

Loretta Johnson works for Icon Strategic Solutions

What is Loretta Johnson's role at the current company?

Loretta Johnson's current role is Senior Clinical Research Associate.

What is Loretta Johnson's email address?

Loretta Johnson's email address is lo****@****plc.com

What schools did Loretta Johnson attend?

Loretta Johnson attended Tennessee State University.

What are some of Loretta Johnson's interests?

Loretta Johnson has interest in Global Taveling.

What skills is Loretta Johnson known for?

Loretta Johnson has skills like Gcp, Clinical Trials, Clinical Monitoring, Clinical Research, Ctms, Edc, Cro, Ich Gcp, Clinical Development, Oncology, Regulatory Submissions, Clinical Data Management.

Not the Loretta Johnson you were looking for?

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.